In a draft statement, the U.S. Preventive Services Task Force renewed its 2004 recommendation against routine ovarian cancer screening, saying a review of 64 studies showed a risk of false positives without a significant decrease in death rates. The panel's recommendation does not cover women at greater risk for ovarian cancer because of family history or known genetic predisposition.
Ovarian cancer screening does more harm than good, USPSTF says
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan